Ph-Ch6: General concepts in TB Treatment
- Goals of treatment
- Strategies for TB Treatment
- Pharmacological Basis of treatment
- Treatment Phases
- Fixed Dose Combinations [FDC]s
- Advantages of FDCs
- FDCs used in NTEP
- TB Drug Regimen
- Follow-up of TB patient
- Long Term Post-treatment follow up of TB patients
- TB Treatment Outcome
- Adverse Drug Reactions
- Types of ADR of TB Treatment
- Management of Adverse Drug Reactions(ADRs) of TB Treatment
- TB Treatment Card
- NTEP TB ID Card
- Transfer of TB Patient
- Management of EPTB
- Management of Patients with Treatment Interruptions
- Prevention of Drug Resistance
- Treatment Regimen for Non-Mycobacterium Tuberculosis [NTM]
Ph-Ch7: DS-TB Treatment and care
PHI Pharmacist : DR-TB TREATMENT AND CARE
- Drug-Resistant Tuberculosis(DR-TB)
- Goals of DR-TB Treatment
- Screening for DR-TB
- Types of Drug Resistance Tuberculosis -DRTB
- DR-TB Treatment Regimens
- Pre-treatment Evaluation [PTE] of DR-TB Patients
- Second Line anti TB drugs
- Newer Anti-TB Drugs
- Weight Band-wise Dosages of DR-TB Drugs for Adults
- Treatment of DR-TB in Children
- Adverse Drug Reactions(ADRs) to Second Line Treatment
- Reporting of Adverse Events and Serious Adverse Events
Ph-Ch9: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
- Shorter oral Bedaquiline-containing MDR/RR-TB regimen
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Dosage of Drugs for Adults
- Possible Adverse Events Due to Drugs in Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
Ph-Ch10: Longer Oral M/XDR-TB Regimen
Ph-Ch11: Isoniazid (H) Mono/Poly DR-TB Regimen
Ph-Ch12: TB Infection treatment and care
Ph-Ch13: TB-Comorbidities and special situations
PHI Pharmacist : GENERAL CONCEPTS IN ADHERENCE MANAGEMENT
for the National TB Elimination Program - NTEP